Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA international commissioner appointed

Executive Summary

FDA appoints Lou Valdez as associate commissioner for international programs, a role in which she will lead implementation of FDA's international programs. Valdez previously served as deputy director in the HHS Office of Global Health Affairs, where she led the development of U.S. government policy positions. She enters her new role at a time of significant expansion of the agency's international presence; in addition to the recent opening of offices in China, FDA announced the opening of its first office in India Jan. 15 (1PharmAsia News, Jan. 15, 2009)

You may also be interested in...

U.S. FDA Opens First Office In India, A “Portal” To The Agency

U.S. Health and Human Services Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach announced Jan. 15 the opening of FDA's first office in India, which will be in New Delhi. An FDA official told PharmAsia News the agency is awaiting permission from India to open a second office in Mumbai

COVID-19 Lessons: Experts Predict Shift Toward Intermittent Hemodialysis In ICUs

The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.

COVID-19: FDA Schedules 4 More Virtual Town Halls Through October

The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts